Liabilities / Assets
60th percentile
Higher debt load relative to assets than 60% of similar nonprofits.
990 • Fiscal year 2023 • EIN 59-3471957
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
60th percentile
Higher debt load relative to assets than 60% of similar nonprofits.
Liabilities / Revenue
48th percentile
Higher debt load relative to revenue than 48% of similar nonprofits.
Net Margin
38th percentile
Higher net margin than 38% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
6th percentile
Faster asset growth than 6% of similar nonprofits.
Revenue Growth
54th percentile
Faster revenue growth than 54% of similar nonprofits.
Assets
Down$2,393,386
Down $657,709 (-22%) from 2022
Net Assets
Down$2,081,501
Down $649,490 (-24%) from 2022
Liabilities
Down$311,885
Down $8,219 (-2.6%) from 2022
Revenue
Up$3,775,413
Up $316,542 (+9.2%) from 2022
Expenses
Up$3,802,734
Up $646,595 (+20%) from 2022
Net Income
Down-$27,321
Down $330,053 (-109%) from 2022
This 2023 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
The foundation provides an innovative environment to host the scientific and technological research of a small group of selected molecular and life scientists to meet opportunities in commerce and medicine.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2023 • Form 990Summary only. Only limited summary data is available for this year.